Unstable Angina
📧 Sign up to get email alerts when something new happens for Unstable Angina.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2018-03-13Clinical Trial Update: Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention [Phase 3]
Phase 3 trial of Aggrastat (tirofiban) in patients undergoing percutaneous coronary intervention for myocardial infarction or acute coronary…
-
CLINICAL_TRIALS withdrawal · 2017-02-20Clinical Trial Update: COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials [Phase 4]
Phase 4 COSTA trials evaluating the COMBO-Stent in patients on chronic anticoagulation have been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-09-16Clinical Trial Update: Acute Coronary Syndrome Sri Lanka Audit Project
The Sri Lanka acute coronary syndrome audit trial sponsored by the University of Colombo has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2010-01-28Clinical Trial Update: Intravenous Isosorbide Dinitrate Versus Sublingual Isosorbide Dinitrate for the Relief of Acute Anginal Episodes in Acute Coronary Syndrome (ACS) Patients [Phase 4]
A Phase 4 trial comparing intravenous and sublingual isosorbide dinitrate for relief of acute anginal episodes in acute coronary syndrome ha…
-
EMA withdrawal · 2008-05-16EMA Withdrawn: Quixidar (fondaparinux sodium) — Glaxo Group Ltd.
The EMA indicates withdrawal of Quixidar (fondaparinux sodium) from the market by Glaxo Group Ltd., covering indications including venous th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.